Therapeutic Goods Legislation Amendment Act 1999
No. 3, 1999
An Act to amend the law relating to therapeutic goods, and for related purposes
Contents
1 Short title......................................1
2 Commencement...................................2
3 Schedule(s).....................................2
Schedule 1—Amendment of the Therapeutic Goods Act 1989 3
4 Objects of Act....................................4
Part 4A—Advertising 6
42A Application...................................6
42B Definitions....................................6
42C Offences relating to publication of advertisements.............6
42D Offences relating to publishers........................7
Part 5B—National Drugs and Poisons Schedule Committee 8
52A Definitions....................................8
52B Establishment and constitution of Committee................8
52C Functions of Committee............................9
52D Poisons Standard................................9
52E Matters to be taken into account in exercising powers..........10
Part 5C—Complementary medicines 11
52F Definitions...................................11
52G Establishment and constitution of Committee...............12
54AA Offences for contravening conditions or requirements imposed under the regulations 12
Schedule 2—Amendment of the Therapeutic Goods Amendment Act 1997 14
25A Registration of therapeutic device to which conformity assessment certificate applies 14
25B Registration of therapeutic device to which conformity assessment certificate applies 14
Therapeutic Goods Legislation Amendment Act 1999
No. 3, 1999
An Act to amend the law relating to therapeutic goods, and for related purposes
[Assented to 29 March 1999]
The Parliament of Australia enacts:
1 Short title
This Act may be cited as the Therapeutic Goods Legislation Amendment Act 1999.
2 Commencement
(1) Subject to this section, this Act commences on a day to be fixed by Proclamation.
(2) If this Act (other than Schedule 2) does not commence under subsection (1) within the period of 6 months beginning on the day on which this Act receives the Royal Assent, it commences on the first day after the end of that period.
(3) Schedule 2 is taken to have commenced immediately after the commencement of Part 2 of Schedule 1 to the Therapeutic Goods Amendment Act 1997.
3 Schedule(s)
Subject to section 2, each Act that is specified in a Schedule to this Act is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this Act has effect according to its terms.
Schedule 1—Amendment of the Therapeutic Goods Act 1989
1 Subsection 3(1)
Insert:
current Poisons Standard has the meaning given by section 52A.
2 Subsection 3(1)
Insert:
first Poisons Standard has the meaning given by section 52A.
3 Subsection 3(1) (definition of foods)
Repeal the definition.
4 Subsection 3(1)
Insert:
medicine means:
(a) therapeutic goods that are represented to achieve, or are likely to achieve, their principal intended action by pharmacological, chemical, immunological or metabolic means in or on the body of a human or animal; and
(b) any other therapeutic goods declared by the Secretary, for the purpose of the definition of therapeutic device, not to be therapeutic devices.
5 Subsection 3(1)
Insert:
poison means an ingredient, compound, material or preparation which, or the use of…
Overview
The Therapeutic Goods Legislation Amendment Act 1999 No. 3, enacted by the Parliament of Australia, was introduced to amend the law relating to therapeutic goods, addressing existing gaps and deficiencies in the regulatory framework. The Act aims to establish and maintain a national system of controls concerning the quality, safety, efficacy, and timely availability of therapeutic goods used or exported from Australia. It also seeks to provide a framework for states and territories to uniformly control the availability and accessibility of poisons, ensuring their safe handling across the country. This legislation allows for the establishment of committees to oversee the classification, scheduling, and evaluation of therapeutic goods and poisons, thereby enhancing the regulatory environment and protecting public health.
Scope and Application
The Therapeutic Goods Legislation Amendment Act 1999 No. 3, 1999, amends the Therapeutic Goods Act 1989 to update and enhance the regulation of therapeutic goods in Australia. The Act applies to therapeutic goods used in or exported from Australia, including medicines and poisons. It provides for the establishment and maintenance of a national system of controls to ensure the quality, safety, efficacy, and timely availability of therapeutic goods. The Act also seeks to provide a framework for the states and territories to adopt a uniform approach to control the availability and accessibility, and ensure the safe handling, of poisons in Australia. The Act's provisions extend to the classification and scheduling of substances, advertising of therapeutic goods, and offences related to contravention of regulations. The Act's application is not intended to exclude state laws that can operate concurrently with the federal legislation. The Act further establishes the National Drugs and Poisons Schedule Committee to make decisions on the classification and scheduling of substances, maintain the Poisons Standard, and provide technical advice to governments. Additionally, it sets up the Complementary Medicines Evaluation Committee to evaluate complementary medicines. The Act allows for the creation of subordinate instruments to extend or restrict its application, such as regulations prescribing specific conditions or requirements for therapeutic goods.
Key Provisions
- The Therapeutic Goods Legislation Amendment Act 1999 (No. 3, 1999) amends the Therapeutic Goods Act 1989 and the Therapeutic Goods Amendment Act 1997. It introduces new provisions concerning the advertising of therapeutic goods, the establishment of a National Drugs and Poisons Schedule Committee, and complementary medicines. Key sections include definitions (sections 42B, 52A, 52F), the establishment and functions of the National Drugs and Poisons Schedule Committee (sections 52B, 52C), and offences related to contraventions of regulatory conditions or requirements (section 54AA).
- This Act imposes several obligations on parties and entities. Firstly, it mandates the establishment of the National Drugs and Poisons Schedule Committee, which is tasked with classifying and scheduling substances, maintaining the Poisons Standard, and providing technical advice to governments (sections 52B, 52C). It also imposes specific requirements on the advertising of therapeutic goods. Advertisements published in mainstream media must be approved, and publishers must not knowingly or recklessly publish unapproved advertisements (sections 42A, 42C, 42D). Furthermore, the Act imposes obligations on holders of licences or permissions to import or export therapeutic goods, requiring them to comply with conditions or requirements set out in the regulations (section 54AA).
- Failure to comply with the provisions of this Act can result in various offences and penalties. For instance, publishing or inserting an unapproved advertisement in mainstream media is an offence punishable by a fine of 100 penalty units (section 42C(2)). Similarly, knowingly or recklessly publishing or inserting an unapproved advertisement can also attract a fine of 100 penalty units (section 42D). Violations of conditions or requirements imposed under the regulations for the import or export of therapeutic goods are punishable by fines of up to 240 penalty units if the contravention relates to public safety, and up to 50 penalty units otherwise (section 54AA).
- Area of Law
- Medical Law
- Instrument
- Act
- Concepts
- Definitions & Interpretation
- Offence Provisions
- Compliance Obligations
- Regulatory Standards